2025-07278Notice

Skalar Pharma Applies to Import Regulated Drugs into US

Published Date: 4/28/2025

Notice

Summary

Skalar Pharma LLC wants to get official approval to import certain controlled substances. This means they’ll be able to bring in specific drugs that are closely watched by the government. If approved, it could affect businesses and researchers who rely on these substances, with no immediate cost changes announced.

Free Policy Watch

New rules are filed every week. Most people never see them.

Pick a topic. PRIA watches every federal rule and tells you when one hits your household.

Pick a topic to get started

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Importer registration application filed

Skalar Pharma LLC has applied to be registered as an importer of basic classes of controlled substances. If approved, they would be allowed to bring in specific government-controlled drugs. The notice says this could affect businesses and researchers who rely on those substances and that no immediate cost changes were announced.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
4/28/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in